PAK4 and breast carcinoma: Because PAK4 nuclear localization correlates with the development of ERα-negative phenotypes, leading to increased metastasis to the bone, searching for therapeutic strategies to block the entry of PAK4 into the nucleus would be useful for preventing breast cancer metastasis in ERα+ breast cancer.